The SFC has instructed HKEX under Rule 8(1) of the Securities and Futures (Stock
Market Listing) Rules to suspend trading in Bokang Shiyun Pharmaceutical-B
(02592.HK) from 09:00 on Sept 10, 2026. The regulator said it is seriously
concerned the company’s IPO may have been artificially manipulated to create
false demand and considers the suspension necessary while it investigates to
preserve an orderly, fair market and protect investors. The investigation is
ongoing and the SFC will not comment further.
